Immediate breast reconstruction for patients with early-stage disease
is well established. This study evaluates a consecutive series of 22 p
atients with locally advanced disease (stage IIB or III) who underwent
mastectomy and immediate breast reconstruction, All patients received
several cycles of neoadjuvant chemotherapy (average, 3.5 cycles) foll
owed by completion of chemotherapy beginning approximately 3 weeks fol
lowing surgery. The perioperative morbidity was 14% and no patient suf
fered a delay in the resumption of chemotherapy, Patients have been pa
rticularly grateful about being offered reconstruction in this setting
, Our preliminary results with this technique have been encouraging an
d further study is warranted.